投稿问答最小化  关闭

万维书刊APP下载
您的位置:万维书刊网 >> 期刊动态

CANCER CONTROL《癌症控制》投稿须知(官网信息)

2021/5/21 16:02:15 来源:官网信息 阅读:2389 发布者:
编者按:以下信息,由万维书刊网根据期刊官网信息整理发布!仅供投稿参考!

Cancer Control

Manuscript Submission Guidelines:

Before you submit your research, please make sure your paper meets the below criteria:

Your paper is an original work and has not been published or currently under review with another journal.

Only authors that have contributed to the work are added. Please see ICMJE's guidelines "Defining Roles of Authors and Contributors".

Your work meets all Research Ethics and Reporting Standards. Many study types require a workflow as a figure and/or a completed checklist uploaded as a supplementary file for peer review. Visit here to see if your study type requires a workflow and/or checklist.

Your figures are of acceptable quality and uploaded as separate files. Line art should be 900-1200 DPI, images 300 DPI. Images should be minimally processed to uphold their original integrity. More figure information here.

Your references are formatted correctly and numbered as they appear in the text. Please visit here for reference style. 

Data and complete methods should be made available so that others may replicate your study. If applicable, please see here for more information and data repositories. 

Authors must have an understanding and agreement to pay any applicable article processing charges (APCs).

Only manuscripts of sufficient quality that meet the aims & scope of the journal will be reviewed.

Full guidelines are below. Submissions that don't adhere to these instructions will be returned prior to peer review.

Once your manuscript meets all criteria above and below, you can submit it through our online submission system here.

This Journal is a member of the Committee on Publication Ethics.

This Journal recommends that authors follow the Recommendations for the Conduct, Reporting, Editing, and Publication of Scholarly Work in Medical Journals formulated by the International Committee of Medical Journal Editors (ICMJE).

Please read the guidelines below then visit the journal’s submission site http//mc.manuscriptcentral.com/ccx to upload your manuscript. Please note that manuscripts not conforming to these guidelines may be returned. Remember you can log in to the submission site at any time to check on the progress of your paper through the peer review process.

SAGE Publishing dissseminates high-quality research and engaged scholarship globally, and we are committed to dirversity and inclusion in publishing. We encourage submissions from a diverse range of authors from across all countries and backgrounds.

Only manuscripts of sufficient quality that meet the aims and scope of Cancer Control will be reviewed.

As part of the submission process, you will be required to warrant that you are submitting your original

work, that you have the rights in the work, that you are submitting the work for first publication in the Journal and that it is not being considered for publication elsewhere and has not already been published elsewhere, and that you have obtained and can supply all necessary permissions for the reproduction of any copyright works not owned by you.

If you have any questions about publishing with SAGE, please visit the SAGE Journal Solutions Portal

Please read the Manuscript Submission Guidelines below before submitting your manuscript here:

SUBMIT MANUSCRIPT

https://mc.manuscriptcentral.com/ccx

1. Open Access

Cancer Control is an open access, peer-reviewed journal. Each article accepted by peer review is made freely available online immediately upon publication is published under a Creative Commons license and will be hosted online in perpetuity. Publication costs of the journal are covered by the collection of article processing charges which are paid by the funder, institution or author of each manuscript upon acceptance. There is no charge for submitting a paper to the journal.

For general information on open access at SAGE please visit the Open Access page or view our Open Access FAQs.

2. Article processing charge (APC)

If, after peer review, your manuscript is accepted for publication, a one-time article processing charge (APC) is payable. This APC covers the cost of publication and ensures that your article will be freely available online in perpetuity under a Creative Commons license.

The article processing charge (APC) for this journal is currently 2300 USD, payable only if your article is accepted after peer review, before it is published.

The APC is subject to taxes where applicable. Tax-exempt status can be indicated by providing appropriate registration numbers when payment is requested. Please see further details here.

3. What do we publish?

3.1 Aims & scope

Before submitting your manuscript to Cancer Control, please ensure you have read the Aims & Scope.

3.2 Article types

At the time of submission, authors are required to answer three questions, which will be incorporated into a “highlights” section at the beginning of the published article.

What do we already know about this topic?

How does your research contribute to the Cancer Control field?

What are your research’s implications towards theory, practice, or policy

Original Research Papers

While there are no strict formatting requirements all manuscripts must still contain abstract, introduction, materials and methods, results, and discussion/conclusion sections.

Please make sure the abstract is a structured abstract with fewer than 250 words. The primary goal of the abstract should be to make the general significance and conceptual advance of the work clearly accessible to a broad readership. References should not be cited in the abstract. Refer to this guide for properly structuring abstracts.

We also ask that you provide 5-10 keywords for indexing purposes.

In the Materials & Methods section, describe the selection of patients or experimental animals, including controls. Do not use patient’s names or hospital numbers. Identify methods, apparatus (manufacturer’s name and address), and procedures in sufficient detail to allow other workers to reproduce the results. Provide references and brief descriptions of methods that have been published. When using new methods, evaluate their advantages and limitations. Identify drugs and chemicals, including generic name, dosage, and route(s) of administration.

Results should be presented in a logical sequence in tables and illustrations. In the text, explain, emphasize or summarize the most important observations. Units of measurement should be expressed in accordance with Systeme International Unites (SI Units).

In the discussion do not repeat in detail data given in the Results section. Emphasize the new and important aspects of the study. Relate observations to other relevant studies. On the basis of your findings (and others), discuss possible implications/conclusions. When stating a new hypothesis, clearly label it as such.

There is no limit for references.

Tables should be numbered consecutively with Arabic numerals and include descriptive titles and legends

Figure legends should be concise, yet descriptive so that the reader can clearly interpret the results being presented.

Brief Reports

These are short experimental papers that may present as little as a single experiment or observation. Brief Reports should constitute unusually interesting data combined with a discussion of what the data might mean, or an explanation of why the data contradicts current paradigms.

The abstract includes a single paragraph of fewer than 150 words. The primary goal of the abstract should be to make the general significance and conceptual advance of the work clearly accessible to a broad readership. Please include 5-10 keywords for indexing purposes.

Reviews

Reviews should be recognized as scholarly by specialists in the covered field, but should also be written with a view to informing readers who are not specialized in that particular field, and should be presented using simple prose. Please avoid excessive jargon and technical detail. Reviews should capture the broad developments and implications of recent work. The opening paragraph should make clear the general thrust of the review and provide a clear sense of why the review is now particularly appropriate. The concluding paragraph should provide the reader with an idea of how the field may develop or future problems to be overcome, but should not summarize the article. To ensure that a review is likely to be accessible to as many readers as possible, it may be useful to ask a colleague from another discipline to read the review before submitting it. Submitted reviews are subject to the same charges as original papers -- whether APCs will apply for commissioned reviews will be made clear when each review is commissioned. Reviews should include an abstract of 150 words and should cite no more than 150 references. Please include 5-10 keywords for indexing purposes.

Auto-commentaries

The Editor or Editorial Board will solicit authors of the most significant recent and forthcoming papers, published elsewhere, to provide a short summary with additional insights, new interpretations or speculation on the relevant topic. These manuscripts may include data or models, which due to space limitations were not included or discussed in the original paper. In other words, the authors may provide biased and uncensored points of views, complementing their article.

Please include an abstract of 150-200 words and 5-10 keywords for indexing purposes. The citation for the original article including the full author list, title of article and journal information should be included on the title page. The typical length of an auto-commentary will be approximately 500-1,000 words and may include up to 30 references.

Commentaries and Views

Commentaries and/or views may be short and focused opinion articles, commentaries on papers recently published in JOURNAL TITLE or elsewhere, or commentaries on significant conceptual changes, important trends or new directions in the field. These may include figures and up to 30 references. Please include an abstract of 150-200 words and 5-10 keywords for indexing purposes.

Journal Club

Journal Club articles to include descriptions and critiques of major advances published in other leading journals. This will be modeled after and driven by journal club presentations held in most institutions around the country.

Technical Papers

Technical papers contain original research, however, they differ from Research Papers in that they describe new approaches, methods, or reagents rather than new understanding of a natural molecule or biological process. Papers may be submitted as either Technical or Research Papers, but the assignment to either category is the discretion of the Editors. All submissions will be peer reviewed.

Letters to the Editor

Letters to the Editor should consist of one or two paragraphs totaling no more than 500 words, no abstract, no subheadings and fewer than 8 references (one author, et al., no titles). If an abstract is included, it will automatically be made the first paragraph. Letters should not include figures or research material. Letters to the editor are not charged an APC.

A letter to the editor is a brief communication that addresses the contents of a published article.

Its purpose is to make corrections, provide alternative viewpoints, or offer counter-arguments. Avoid logical fallacies and ad hominem attacks. Letters to the editor must be written in a professional tone and include references to support all claims if appropriate.

Validation Studies

Validation or Replication studies can be submitted to the journal. These should be carried out to validate that a scientific finding is accurate, reliable and reproducible. These may be written in the style of a Brief Communication or a Research Paper with a brief introduction.

3.3 Writing your paper

The SAGE Author Gateway has some general advice and on how to get published, plus links to further resources.

3.3.1 Making your article discoverable

When writing up your paper, think about how you can make it discoverable. The title, keywords and abstract are key to ensuring readers find your article through search engines such as Google. For information and guidance on how best to title your article, write your abstract and select your keywords, have a look at this page on the Gateway: How to Help Readers Find Your Article Online.

4. Editorial policies

4.1 Peer review policy

Following a preliminary triage to eliminate submissions unsuitable for Cancer Control all papers are sent out for review. The covering letter is important. To help the Editor in his preliminary evaluation, please indicate why you think the paper suitable for publication.

The journal’s policy is to have manuscripts reviewed by two expert reviewers. Cancer Control utilizes a double-blind peer review process in which the reviewer and authors’ names and information are withheld from the other. All manuscripts are reviewed as rapidly as possible while maintaining rigor. Reviewers make comments to the author and recommendations to the Section Editor and Editor-in-Chief who then makes the final decision.

The Editor or members of the Editorial Board may occasionally submit their own manuscripts for possible publication in the journal. In these cases, the peer review process will be managed by alternative members of the Board and the submitting Editor / Board member will have no involvement in the decision-making process.

4.2 Authorship

Papers should only be submitted for consideration once consent is given by all contributing authors. Those submitting papers should carefully check that all those whose work contributed to the paper are acknowledged as contributing authors.

The list of authors should include all those who can legitimately claim authorship. This is all those who:

(i) Made a substantial contribution to the concept or design of the work; or acquisition, analysis or interpretation of data,

(ii) Drafted the article or revised it critically for important intellectual content, (iii) Approved the version to be published,

(iv) Each author should have participated sufficiently in the work to take public responsibility for appropriate portions of the content.

Authors should meet the conditions of all of the points above. Each author should have participated sufficiently in the work to take public responsibility for appropriate portions of the content.

When a large, multicentre group has conducted the work, the group should identify the individuals who accept direct responsibility for the manuscript. These individuals should fully meet the criteria for authorship.

Acquisition of funding, collection of data, or general supervision of the research group alone does not constitute authorship, although all contributors who do not meet the criteria for authorship should be listed in the Acknowledgments section. Please refer to the International Committee of Medical Journal Editors (ICMJE) authorship guidelines for more information on authorship.

4.3 Acknowledgements

All contributors who do not meet the criteria for authorship should be listed in an Acknowledgements section. Examples of those who might be acknowledged include a person who provided purely technical help, or a department chair who provided only general support.

4.3.1 Third party submissions

Where an individual who is not listed as an author submits a manuscript on behalf of the author(s), a statement must be included in the Acknowledgements section of the manuscript and in the accompanying cover letter. The statements must:

    Disclose this type of editorial assistance – including the individual’s name, company and level of input

    Identify any entities that paid for this assistance

    Confirm that the listed authors have authorized the submission of their manuscript via third party and approved any statements or declarations, e.g. conflicting interests, funding, etc.

Where appropriate, SAGE reserves the right to deny consideration to manuscripts submitted by a third party rather than by the authors themselves.

4.3.2 Writing assistance

Individuals who provided writing assistance, e.g. from a specialist communications company, do not qualify as authors and so should be included in the Acknowledgements section. Authors must disclose any writing assistance – including the individual’s name, company and level of input – and identify the entity that paid for this assistance. It is not necessary to disclose use of language polishing services. Please supply any personal acknowledgments separately to the main text to facilitate anonymous peer review.

4.4 Funding

Cancer Control requires all authors to acknowledge their funding in a consistent fashion under a separate heading. Please visit the Funding Acknowledgements page on the SAGE Journal Author Gateway to confirm the format of the acknowledgment text in the event of funding, or state that: This research received no specific grant from any funding agency in the public, commercial, or not-for-profit sectors.

4.5 Declaration of conflicting interests

It is the policy of Cancer Control to require a declaration of conflicting interests from all authors enabling a statement to be carried within the paginated pages of all published articles. Please ensure that a ‘Declaration of Conflicting Interests’ statement is included at the end of your manuscript, after any acknowledgments and prior to the references. If no conflict exists, please state that ‘The Author(s) declare(s) that there is no conflict of interest’.

For guidance on conflict of interest statements, please see the ICMJE recommendations.

4.6 Research ethics and patient consent

IMPORTANT: If you are reporting on animal and/or human studies, please ensure that you include a section on research ethics and, where applicable, patient consent, at the end of your manuscript.

Medical research involving human subjects must be conducted according to the World Medical Association Declaration of Helsinki.

Submitted manuscripts should conform to the ICMJE Recommendations for the Conduct, Reporting, Editing, and Publication of Scholarly Work in Medical Journals, and all papers reporting animal and/or human studies must state the relevant Ethics Committee or Institutional Review Board provided (or waived) approval. Please ensure that you have provided the full name and institution of the review committee, in addition to the approval number.

For research articles, authors are also required to state whether participants provided informed consent and whether the consent was written or verbal.

Information on informed consent to report individual cases or case series should be included in the manuscript text. A statement is required regarding whether written informed consent for patient information and images to be published was provided by the patient(s) or a legally authorized representative. Please do not submit the patient’s actual written informed consent with your article, as this in itself breaches the patient’s confidentiality. The Journal requests that you confirm to us, in writing, that you have obtained written informed consent but the written consent itself should be held by the authors/investigators themselves, for example in a patient’s hospital record. The confirmatory letter may be uploaded with your submission as a separate file.

Please also refer to the ICMJE Recommendations for the Protection of Research Participants

All research involving animals submitted for publication must be approved by an ethics committee with oversight of the facility in which the studies were conducted. The journal has adopted the Consensus Author Guidelines on Animal Ethics and Welfare for Veterinary Journals published by the International Association of Veterinary Editors.

……

更多详情:

https://journals.sagepub.com/author-instructions/CCX


本文评论

暂无相应记录!

首页<<1>>尾页共0页共0条记录
  • 万维QQ投稿交流群    招募志愿者

    版权所有 Copyright@2009-2015豫ICP证合字09037080号

     纯自助论文投稿平台    E-mail:eshukan@163.com